Molsyns Research manufactures high-purity Nitrosamine impurities and N-nitroso reference standards (NDMA, NDEA, NDIPA, etc.) to support pharmaceutical companies in risk assessment and toxicology studies. Since nitrosamines are classified as potential human carcinogens, our Ahmedabad facility synthesizes ultra-pure compounds with full analytical validation to meet stringent global regulatory standards.